Back to Search
Start Over
Design, synthesis and biological evaluation of 1-aryldonepezil analogues as anti-Alzheimer's disease agents.
- Source :
-
Future medicinal chemistry [Future Med Chem] 2024; Vol. 16 (10), pp. 983-997. Date of Electronic Publication: 2024 May 16. - Publication Year :
- 2024
-
Abstract
- Aim: To design and synthesize a novel series of 1-aryldonepezil analogues. Materials & methods: The 1-aryldonepezil analogues were synthesized through palladium/PCy <subscript>3</subscript> -catalyzed Suzuki reaction and were evaluated for cholinesterase inhibitory activities and neuroprotective effects. In silico docking of the most effective compound was conducted. Results: The 4- tert -butylphenyl analogue exhibited good inhibitory potency against acetylcholinesterase and butyrylcholinesterase and had a favorable neuroprotective effect on H <subscript>2</subscript> O <subscript>2</subscript> -induced SH-SY5Y cell injury. Conclusion: The 4- tert -butylphenyl derivative is a promising lead compound for anti-Alzheimer's disease drug development.
- Subjects :
- Humans
Structure-Activity Relationship
Piperidines chemistry
Piperidines pharmacology
Piperidines chemical synthesis
Molecular Structure
Cell Line, Tumor
Hydrogen Peroxide pharmacology
Hydrogen Peroxide antagonists & inhibitors
Indoles
Alzheimer Disease drug therapy
Alzheimer Disease metabolism
Cholinesterase Inhibitors pharmacology
Cholinesterase Inhibitors chemical synthesis
Cholinesterase Inhibitors chemistry
Drug Design
Neuroprotective Agents pharmacology
Neuroprotective Agents chemical synthesis
Neuroprotective Agents chemistry
Acetylcholinesterase metabolism
Butyrylcholinesterase metabolism
Molecular Docking Simulation
Subjects
Details
- Language :
- English
- ISSN :
- 1756-8927
- Volume :
- 16
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Future medicinal chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 38910574
- Full Text :
- https://doi.org/10.4155/fmc-2023-0369